Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
124.03
+3.17 (2.62%)
Jan 14, 2025, 4:00 PM EST - Market closed
Cardinal Health Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 132.46, with a low estimate of 120 and a high estimate of 145. The average target predicts an increase of 6.80% from the current stock price of 124.03.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CAH stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 4 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 5 | 5 | 5 | 5 | 6 | 5 |
Sell | 1 | 1 | 1 | 1 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12 | 12 | 12 | 12 | 12 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Hold Maintains $120 → $129 | Hold | Maintains | $120 → $129 | +4.01% | Jan 10, 2025 |
TD Cowen | TD Cowen | Hold → Strong Buy Upgrades $130 → $144 | Hold → Strong Buy | Upgrades | $130 → $144 | +16.10% | Jan 8, 2025 |
Evercore ISI Group | Evercore ISI Group | Hold → Buy Upgrades $140 | Hold → Buy | Upgrades | $140 | +12.88% | Jan 7, 2025 |
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $132 → $145 | Hold → Strong Buy | Upgrades | $132 → $145 | +16.91% | Jan 6, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $127 → $136 | Buy | Maintains | $127 → $136 | +9.65% | Dec 17, 2024 |
Financial Forecast
Revenue This Year
222.47B
from 226.83B
Decreased by -1.92%
Revenue Next Year
240.93B
from 222.47B
Increased by 8.30%
EPS This Year
7.92
from 3.45
Increased by 129.44%
EPS Next Year
8.78
from 7.92
Increased by 10.97%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 234.8B | 257.5B | 282.3B | ||
Avg | 222.5B | 240.9B | 257.9B | ||
Low | 209.0B | 226.2B | 237.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.5% | 15.7% | 17.2% | ||
Avg | -1.9% | 8.3% | 7.0% | ||
Low | -7.9% | 1.7% | -1.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.35 | 9.44 | 10.62 | ||
Avg | 7.92 | 8.78 | 9.68 | ||
Low | 7.63 | 8.24 | 9.03 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 142.0% | 19.3% | 20.8% | ||
Avg | 129.4% | 11.0% | 10.2% | ||
Low | 121.3% | 4.1% | 2.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.